Agilent and University of Vermont Announce Collaboration
Agilent Technologies Inc. (Santa Clara, California, USA) and the University of Vermont (UVM) (Vermont, USA) have announced the establishment of the Agilent Laboratory for Chemical Analysis (ALCA). The facility will feature advanced instrumentation allowing students, institutional colleagues, industrial partners, and regional high-tech start-ups to study the composition and structure of chemical samples. The site will act as a shared educational and research space for educational purposes while also serving as a valuable technology resource to local and regional businesses.
“Agilent is extremely pleased to support UVM in the development of this innovative research facility,” said Mike McMullen, Agilent President and CEO. “It’s another example of Agilent’s commitment to advancing scientific understanding and at the same time supporting UVM and the local community.”
The fast pace of technological advancement can be a challenge for educational facilities such as universities or research facilities. However, the suite of Agilent instrumentation housed in the ALCA facility will advance long-term technical and scientific goals in the state of Vermont and support economic and technological sustainability throughout the region.
“This new state-of-the-art instrumentation laboratory will fulfill a primary need in academia, where we have an obligation to ensure the next generation of scientists have the technical skills required to meet modern challenges,” said Dr. Giuseppe Petrucci, Professor of Chemistry at the University of Vermont. “Beyond that, the fact that this lab will also be available to faculty members for research projects, as well as to start-up companies in the area, offers tremendous opportunities to advance scientific discovery and validation.”
The University of Vermont is hopeful the ALCA facility will establish an “incubator” environment where users can develop and share ideas and tackle challenging analytical problems in a dynamic and scientifically driven environment. The laboratory will also serve as a regional hub for Agilent representatives to showcase and demonstrate instrumentation functions and capabilities.
For more information please visit: www.agilent.com or www.uvm.edu
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
